{"name":"Handok Inc.","slug":"handok-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"oncology","drugs":[{"name":"Amlodipine High","genericName":"Amlodipine High","slug":"amlodipine-high","indication":"Hypertension","status":"phase_2"},{"name":"Irbesartan/Amlodipine","genericName":"Irbesartan/Amlodipine","slug":"irbesartan-amlodipine","indication":"Hypertension","status":"phase_3"},{"name":"Irbesartan/Amlodipine high","genericName":"Irbesartan/Amlodipine high","slug":"irbesartan-amlodipine-high","indication":"Hypertension","status":"phase_3"},{"name":"Irbesartan/Amlodipine low","genericName":"Irbesartan/Amlodipine low","slug":"irbesartan-amlodipine-low","indication":"Hypertension","status":"phase_3"}]},{"name":"Respiratory","slug":"respiratory","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"Ciclesonide & Levocetirizine","genericName":"Ciclesonide & Levocetirizine","slug":"ciclesonide-levocetirizine","indication":"Allergic rhinitis with asthma or allergic airway disease","status":"marketed"},{"name":"MP513","genericName":"MP513","slug":"mp513","indication":"Chronic obstructive pulmonary disease (COPD)","status":"phase_3"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"cardiovascular","drugs":[{"name":"Glimepiride/metformin fixed combination","genericName":"Glimepiride/metformin fixed combination","slug":"glimepiride-metformin-fixed-combination","indication":"Type 2 diabetes mellitus","status":"marketed"},{"name":"Teneligliptin Placebo Oral Tablet","genericName":"Teneligliptin Placebo Oral Tablet","slug":"teneligliptin-placebo-oral-tablet","indication":"Type 2 diabetes","status":"phase_3"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"neuroscience","drugs":[{"name":"Ketoprofen topical","genericName":"Ketoprofen topical","slug":"ketoprofen-topical","indication":"Topical treatment of localized pain and inflammation associated with musculoskeletal conditions","status":"phase_3"}]}],"pipeline":[{"name":"Amlodipine High","genericName":"Amlodipine High","slug":"amlodipine-high","phase":"phase_2","mechanism":"Calcium channel blocker","indications":["Hypertension","Angina"],"catalyst":""},{"name":"Ciclesonide & Levocetirizine","genericName":"Ciclesonide & Levocetirizine","slug":"ciclesonide-levocetirizine","phase":"marketed","mechanism":"Ciclesonide is an inhaled corticosteroid that reduces airway inflammation, while levocetirizine is a selective H1-receptor antagonist that blocks histamine-mediated allergic responses.","indications":["Allergic rhinitis with asthma or allergic airway disease"],"catalyst":""},{"name":"Glimepiride/metformin fixed combination","genericName":"Glimepiride/metformin fixed combination","slug":"glimepiride-metformin-fixed-combination","phase":"marketed","mechanism":"This combination reduces blood glucose by stimulating insulin secretion from pancreatic beta cells (glimepiride) and decreasing hepatic glucose production while improving insulin sensitivity (metformin).","indications":["Type 2 diabetes mellitus"],"catalyst":""},{"name":"Irbesartan/Amlodipine","genericName":"Irbesartan/Amlodipine","slug":"irbesartan-amlodipine","phase":"phase_3","mechanism":"This combination blocks angiotensin II receptors and calcium channels to reduce blood pressure through vasodilation and decreased vascular resistance.","indications":["Hypertension"],"catalyst":""},{"name":"Irbesartan/Amlodipine high","genericName":"Irbesartan/Amlodipine high","slug":"irbesartan-amlodipine-high","phase":"phase_3","mechanism":"This combination drug blocks angiotensin II receptors and calcium channels to reduce blood pressure through dual vasodilation and reduced vascular resistance.","indications":["Hypertension"],"catalyst":""},{"name":"Irbesartan/Amlodipine low","genericName":"Irbesartan/Amlodipine low","slug":"irbesartan-amlodipine-low","phase":"phase_3","mechanism":"This combination drug lowers blood pressure by blocking angiotensin II receptors (irbesartan) and calcium channels (amlodipine) to reduce vascular resistance and improve blood flow.","indications":["Hypertension"],"catalyst":""},{"name":"Ketoprofen topical","genericName":"Ketoprofen topical","slug":"ketoprofen-topical","phase":"phase_3","mechanism":"Ketoprofen is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis, thereby decreasing inflammation and pain at the site of topical application.","indications":["Topical treatment of localized pain and inflammation associated with musculoskeletal conditions","Osteoarthritis pain relief"],"catalyst":""},{"name":"MP513","genericName":"MP513","slug":"mp513","phase":"phase_3","mechanism":"MP513 is a selective inhibitor of phosphodiesterase 4 (PDE4) that reduces inflammatory mediator production by increasing intracellular cAMP levels.","indications":["Chronic obstructive pulmonary disease (COPD)"],"catalyst":""},{"name":"Teneligliptin Placebo Oral Tablet","genericName":"Teneligliptin Placebo Oral Tablet","slug":"teneligliptin-placebo-oral-tablet","phase":"phase_3","mechanism":"Teneligliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that increases the levels of incretin hormones, enhancing glucose-dependent insulin secretion.","indications":["Type 2 diabetes"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-04-03","type":"pipeline","source":"GuruFocus","summary":"Stock List: Research Stocks from Around the World - GuruFocus","headline":"Stock List: Research Stocks from Around the World","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBQNklPdXhlb2ZaS3pRc2hCY0doS09yWkJxVE03OEZTb1QtTmV5MGYzcnJQTEUyUWdnOHg0RUZlbEJuUmNoTWFXNDBQd0hkWmk1Q0MtMGlEWHY4NENVeXBSTEQxVVRheVB1Uy1LYnJ30gFyQVVfeXFMUEViQnNBazkya3Rhd3hzWmxxRWtqZFNkMmxvUjk3MTY5OVROSl8waUh3aVB1RUpKcHNuOHUzdnVXaVF6cHJCMVVTVXVpTTgtcXRTYVpYVjc2UXZWa3V4Sm56RlN2X3A3bFJReGVWMXFTck53?oc=5","date":"2026-03-05","type":"pipeline","source":"koreabiomed.com","summary":"Korean pharma braces for governance reforms, CEO renewals in March meetings - koreabiomed.com","headline":"Korean pharma braces for governance reforms, CEO renewals in March meetings","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1jeE1jYnpfaHBuMlpkSGN2c2RmclVaYmZCRVl4S0t5bkJXMjFsTFlMNnh3OUVqWlFLVVpObU1OdzAxQ0x1c2ZCdDlMd2JXS0JxdGJwQk9ObzBCMWFjM21hb3g3MElFZUtGei1ia3dB?oc=5","date":"2026-01-23","type":"pipeline","source":"KED Global","summary":"S.Korea speeds homegrown weight-loss drug development led by Hanmi Pharm - KED Global","headline":"S.Korea speeds homegrown weight-loss drug development led by Hanmi Pharm","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiS0FVX3lxTE1LOGV5V2d0azJQdEtfUDFIVE1TYjdDVmg5UEVVX2FsenRQemlDSlh1cmplTWxSWnU2VUNmUmZqdmlLQVVVZ0Z4bFV4QQ?oc=5","date":"2025-04-05","type":"pipeline","source":"매일경제","summary":"Hello, MK Pharmacy readers! Now, the weather is quite warm enough to find people walking in the midd.. - 매일경제","headline":"Hello, MK Pharmacy readers! Now, the weather is quite warm enough to find people walking in the midd.. - 매일경제","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBONVNsS1R2TDdjVTlwdGZvMThFVHg3SVN4WUEwZjJfbldKVWNPdTZyTkNEdHJBYU5pUy1YbzRxcTZuWmlXbWI4czJVblhRckttUTZ2cHQ5aFlodUZGUkVRMDBCUElXRUxVLWwtVzRB?oc=5","date":"2024-05-24","type":"pipeline","source":"KED Global","summary":"Handok gets Biocon's obesity drug exclusive distribution in S.Korea - KED Global","headline":"Handok gets Biocon's obesity drug exclusive distribution in S.Korea","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxPWmg3bzZzMEVvZ1dKV2E3LW0wcl95TWFLc0EzZnhhYmZ6ZVFleXNxc2g0cEpVeG5tRG1fWUpQY3hxWjNpUEdhd0R0N3g4WjdEREZjLWtqaFVnOWticUJvc19xNnQ1ci0yZHQ1YnltMFpvZ25Cb3VGcXhfSVdtWmtMUU51VkRQSmpoS3U4S20taU9EUFp1Ukt1R0MwNjg4LVhJLWV6NjlfMFhaRzBiYlg3QmJEY2EzbExZOHEtcGtn?oc=5","date":"2024-04-16","type":"deal","source":"BioSpectrum Asia","summary":"Nxera Pharma inks deal with Handok to distribute PIVLAZ in South Korea - BioSpectrum Asia","headline":"Nxera Pharma inks deal with Handok to distribute PIVLAZ in South Korea","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiV0FVX3lxTE1WY3BnN2xIa2FOMGdORWR6RU9scDcyOS0zby1DM096bWUwNmpuS2FtOWdlanM1V251NE9aTlNBSW5qYjZrWUJfbE5naENWWlNMR3QtZEk5SQ?oc=5","date":"2024-02-14","type":"pipeline","source":"매일경제","summary":"Handok, Sobi to collaborate on rare disease treatment - 매일경제","headline":"Handok, Sobi to collaborate on rare disease treatment - 매일경제","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1RY0JfRGh5VFVZUmVNNGZkMnY3UHc4Z21RNkxoOC1pMXBxaWdnWXNWdEVoMlFESlUzUjJNYV80NzUzYy1scUV2enZ1VzJ5UGZsek9oeWN0czlxaWVUQ0F5ME02SS1rRDRMOW0zcldR?oc=5","date":"2023-08-31","type":"pipeline","source":"KED Global","summary":"Handok to import treatment for rare autoimmune disorder - KED Global","headline":"Handok to import treatment for rare autoimmune disorder","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5lbXhzcUhESUVGSzBxYTNZYWdPeUZ5bjBVenpFRTNGdktzcE1iNFZQbHhPcUJKeG5KTGt6Wl9rQVhDd3NaZlNiaHBaSUFGRmZwRnMzV2p1T0ZaU2xXSTZCc1FaWGg0VS1xLU5hVmFn0gFyQVVfeXFMT3BsLU8tdFFWSlJ3TXItZnF0ZHBxeFZjWjVwbXA4TGxBTjVUX0hoRE9FWUx0R05TbUdRdnZ3cmhmVk5ET2tVMXcwb29fU0VLc3NQR3kwekhQWUpWbVV2M0t3SFNYbWhqaV9kUDhyN1p2R3Jn?oc=5","date":"2021-02-19","type":"pipeline","source":"koreabiomed.com","summary":"Handok’s Soliris expands indication to NMOSD - koreabiomed.com","headline":"Handok’s Soliris expands indication to NMOSD","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWkFVX3lxTFBzTTFabW1JUmY2bWJlN0JsUDlKWEdnZTZHUk5vdDR4UHA4M2ZzNi0tMjY5UElvZnYwNmpOVkU3UkVWWkcxZFlsZ1pwTFhWQ2VOUTctTmhNYTFuZw?oc=5","date":"2019-01-08","type":"pipeline","source":"Yonhap News Agency","summary":"Handok Pharmaceutical, Genexine purchase U.S. bio firm - Yonhap News Agency","headline":"Handok Pharmaceutical, Genexine purchase U.S. bio firm","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxPZzNXY1Q2dDA1ZUhOZ1RUU0xraE5uR2c5NTBVLVRZMm9nR0ptTkd5LWwtYzY5VzB3N1VmVTdsX0Q0YWl1ZEQweU41VWwxcEJFWWtOM24tUm9vcjBDN0FsbnhFZ3dxNFRIYk1rZFFPdV94dEJabjRYMTZxN1BvNmtBMlFhZE5QVHk3Z0MtUU1zdw?oc=5","date":"2018-01-04","type":"pipeline","source":"News at IU","summary":"IU Kelley School dean and two alumni participating in Olympic torch relay in Seoul - News at IU","headline":"IU Kelley School dean and two alumni participating in Olympic torch relay in Seoul","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWEFVX3lxTE5Jelc0cUJOU3RXTlJQUlU4Tk5vdWh0TzNOMFg2X3F2eXhqSzBpOGY4OERPUGlTRjBFb1hycGtseE5iUGtLSWFKTzBUQTJ4c1hQbHBLMDlEMXY?oc=5","date":"2016-11-08","type":"deal","source":"theinvestor.co.kr","summary":"Handok acquires Theravalues in $18.5 million deal - theinvestor.co.kr","headline":"Handok acquires Theravalues in $18.5 million deal","sentiment":"neutral"}],"patents":[],"drugCount":9,"phaseCounts":{"phase_2":1,"marketed":2,"phase_3":6},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}